These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1308 related articles for article (PubMed ID: 19593084)

  • 1. Total cystectomy versus bladder preservation therapy for locally invasive bladder cancer: effect of combined therapy using balloon-occluded arterial infusion of anticancer agent and hemodialysis with concurrent radiation.
    Azuma H; Yamamoto K; Inamoto T; Ibuki N; Kotake Y; Sakamoto T; Kiyama S; Ubai T; Takahara K; Segawa N; Narumi Y; Katsuoka Y
    Am J Clin Oncol; 2009 Dec; 32(6):592-606. PubMed ID: 19593084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of combined therapy using balloon-occluded arterial infusion of cisplatin and hemodialysis with concurrent radiation for locally invasive bladder cancer.
    Azuma H; Kotake Y; Yamamoto K; Sakamoto T; Kiyama S; Ubai T; Inamoto T; Takahara K; Matsuki M; Segawa N; Shibahara N; Katsuoka Y
    Am J Clin Oncol; 2008 Feb; 31(1):11-21. PubMed ID: 18376222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel bladder preservation therapy for locally invasive bladder cancer: combined therapy using balloon-occluded arterial infusion of anticancer agent and hemodialysis with concurrent radiation.
    Azuma H; Inamoto T; Ibuki N; Ubai T; Kotake Y; Takahara K; Kiyama S; Nomi H; Uehara H; Komura K; Yamamoto K; Narumi Y; Katsuoka Y
    Int J Oncol; 2010 Oct; 37(4):773-85. PubMed ID: 20811698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The novel bladder preservation therapy BOAI-CDDP-radiation (OMC-regimen): a new treatment option for invasive bladder cancer patients with lymph node metastasis.
    Azuma H; Inamoto T; Takahara K; Nomi H; Hirano H; Ibuki N; Uehara H; Komura K; Minami K; Uchimoto T; Saito K; Takai T; Tanda N; Yamamoto K; Narumi Y; Kiyama S
    Int J Oncol; 2014 Jun; 44(6):1895-903. PubMed ID: 24728124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of the novel bladder preservation therapy, BOAI-CDDP-radiation (OMC-regimen), for elderly patients with invasive bladder cancer.
    Azuma H; Inamoto T; Ibuki N; Ubai T; Kotake Y; Takahara K; Kiyama S; Nomi H; Uehara H; Komura K; Yamamoto K; Narumi Y; Katsuoka Y
    Int J Oncol; 2011 Jan; 38(1):13-24. PubMed ID: 21109921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a novel bladder preservation therapy, BOAI-CDDP-radiation (OMC-regimen).
    Azuma H; Inamoto T; Takahara K; Nomi H; Uehara H; Komura K; Minami K; Kouno J; Kotake Y; Abe H; Takagi S; Yamamoto K; Narumi Y; Kiyama S
    Int J Oncol; 2013 Jul; 43(1):79-87. PubMed ID: 23624911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A great option for elderly patients with locally invasive bladder cancer, BOAI-CDDP-radiation (OMC regimen).
    Azuma H; Inamoto T; Takahara K; Nomi H; Hirano H; Uehara H; Komura K; Minami K; Kouno J; Kotake Y; Abe H; Takagi S; Ibuki N; Yamamoto K; Narumi Y; Kiyama S
    Int J Oncol; 2013 Oct; 43(4):1087-94. PubMed ID: 23934264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow up of patients with invasive bladder carcinoma receiving combined cisplatin-based intra-arterial chemotherapy and radiotherapy.
    Mori K; Nomata K; Noguchi M; Eguchi J; Hayashi N; Kanetake H
    Int J Urol; 2007 Jul; 14(7):591-4. PubMed ID: 17645599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
    George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
    Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel bladder preservation therapy with Osaka Medical College regimen.
    Azuma H; Inamoto T; Takahara K; Nomi H; Hirano H; Ibuki N; Uehara H; Komura K; Minami K; Uchimoto T; Saito K; Takai T; Tanda N; Yamamoto K; Narumi Y; Kiyama S
    J Urol; 2015 Feb; 193(2):443-50. PubMed ID: 25167990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The results of concurrent chemo-radiotherapy for recurrence after treatment with bacillus Calmette-Guérin for non-muscle-invasive bladder cancer: is immediate cystectomy always necessary?
    Wo JY; Shipley WU; Dahl DM; Coen JJ; Heney NM; Kaufman DS; Zietman AL
    BJU Int; 2009 Jul; 104(2):179-83. PubMed ID: 19154448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination cisplatin, 5-fluorouracil and radiation therapy for locally advanced unresectable or medically unfit bladder cancer cases: a Southwest Oncology Group Study.
    Hussain MH; Glass TR; Forman J; Sakr W; Smith DC; Al-Sarraf M; Jones J; Balcerzak SP; Crawford ED; Grossman HB
    J Urol; 2001 Jan; 165(1):56-60; discussion 60-1. PubMed ID: 11125363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose chemoradiotherapy followed by partial or radical cystectomy against muscle-invasive bladder cancer: an intent-to-treat survival analysis.
    Koga F; Yoshida S; Kawakami S; Kageyama Y; Yokoyama M; Saito K; Fujii Y; Kobayashi T; Kihara K
    Urology; 2008 Aug; 72(2):384-8. PubMed ID: 18455771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results of long-term treatment of inoperable cancer of the bladder with cisplatin and concurrent irradiation: prognostic factors of local control and survival].
    Chauvet B; Félix-Faure C; Davin JL; Choquenet C; Alfonsi M; Reboul F
    Cancer Radiother; 1998 Apr; 2 Suppl 1():85s-91s. PubMed ID: 9749086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetramodal therapy using balloon-occluded arterial infusion of anticancer agents, the Azuma regimen, for lymph node-involved bladder cancer.
    Azuma H; Inamoto T; Takahara K; Ibuki N; Nomi H; Komura K; Uehara H; Minami K; Yamamoto K; Narumi Y
    Int J Oncol; 2019 Jan; 54(1):167-176. PubMed ID: 30387836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of two-port and four-port irradiation in the bladder preservation therapy for locally invasive bladder cancer.
    Sawada Y; Takeuchi Y; Iwasawa T; Kuroda K; Matsushima M; Nagamoto M; Wakayama M
    Int J Urol; 2006 Dec; 13(12):1470-4. PubMed ID: 17118019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conservative treatment of invasive bladder carcinoma by transurethral resection, protracted intravenous infusion chemotherapy, and hyperfractionated radiotherapy: long term results.
    Danesi DT; Arcangeli G; Cruciani E; Altavista P; Mecozzi A; Saracino B; Orefici F
    Cancer; 2004 Dec; 101(11):2540-8. PubMed ID: 15481058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I-II RTOG study (99-06) of patients with muscle-invasive bladder cancer undergoing transurethral surgery, paclitaxel, cisplatin, and twice-daily radiotherapy followed by selective bladder preservation or radical cystectomy and adjuvant chemotherapy.
    Kaufman DS; Winter KA; Shipley WU; Heney NM; Wallace HJ; Toonkel LM; Zietman AL; Tanguay S; Sandler HM
    Urology; 2009 Apr; 73(4):833-7. PubMed ID: 19100600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An organ-sparing treatment using combined intra-arterial chemotherapy and radiotherapy for muscle-invading bladder carcinoma.
    Tsukamoto S; Ishikawa S; Tsutsumi M; Nakajima K; Sugahara S
    Scand J Urol Nephrol; 2002; 36(5):339-43. PubMed ID: 12487737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcome of radiation-based conservation therapy for invasive bladder cancer.
    Chung PW; Bristow RG; Milosevic MF; Yi QL; Jewett MA; Warde PR; Catton CN; McLean M; Moore M; Tannock IF; Gospodarowicz MK
    Urol Oncol; 2007; 25(4):303-9. PubMed ID: 17628296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 66.